EU clears Abbott acquisition of Alere subject to divestments

BRUSSELS, Jan 25 (Reuters) - European Union antitrust

regulators cleared Abbott Laboratories' proposed $5.8

billion acquisition of diagnostic test maker Alere on

Wednesday, subject to the divestment of some of Alere's

operations.

Read more